Infection News

Patients who underwent two-stage revision total hip arthroplasty for periprosthetic joint infection had a minimum 2-year infection-free survivorship of 73.8% and improved patient-reported outcomes at midterm to long-term follow-up.

SAN ANTONIO — Rates of surgical site infections drastically improved after implementing a comprehensive prevention bundle, researchers reported at the Association for Professionals in Infection Control and Epidemiology annual meeting.

Published results showed antibiotic-loaded bone cement may not be warranted for prophylaxis with total knee arthroplasty due to the additional cost and similar rates of revision for periprosthetic joint infection vs. plain bone cement.

OsteoRemedies LLC announced FDA clearance for expanded indications of its Spectrum GV dual antibiotic bone cement for the use in revision total hip arthroplasty procedures, according to a press release.

Postoperative chemotherapy may be associated with increased risk of periprosthetic joint infection after total joint arthroplasty, according to published results.

Osteomyelitis is a microbial infection of the bone. Pediatric osteomyelitis is common and has increased with time.

Despite suppressive antibiotic therapy being a routine strategy for managing periprosthetic joint infections, a study showed the benefits may be limited.

Periprosthetic joint infection remains one of the most dreaded complications following joint arthroplasty.

Published results showed extended oral antibiotic prophylaxis was not associated with a reduced risk of periprosthetic joint infection at 90 days or 1 year among patients who underwent total hip or total knee arthroplasty.

According to published results, prophylactic intraoperative incisional wound irrigation with an antiseptic solution was associated with reduced surgical site infections compared with use of either an antibiotic solution or no irrigation.